Cobamamide and Fenofibrate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cobamamide (dibencozide) and Fenofibrate (fenofibrate). Common drug interactions include acute myocardial infarction among females and blood urea increased among males.

The phase IV clinical study analyzes what interactions people have when they take Cobamamide and Fenofibrate. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Cobamamide?

Cobamamide has active ingredients of dibencozide. eHealthMe is studying from 1,046 Cobamamide users. Check the latest studies of Cobamamide.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,456 Fenofibrate users. Check the latest studies of Fenofibrate.



On Jul, 25, 2026

14 people who take Cobamamide and Fenofibrate together, and have interactions are studied.

Cobamamide and Fenofibrate drug interactions.

What are the common drug interactions of Cobamamide and Fenofibrate, by gender? *:

female:

  1. Acute myocardial infarction (acute heart attack)
  2. Mitral valve incompetence (inefficient heart valve)
  3. Pulmonary valve incompetence
  4. Troponin increased
  5. Abscess (pus)
  6. Acute respiratory failure
  7. Back pain
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Cellulitis (infection under the skin)
  10. Cholecystitis infective (infection of gallbladder capable to infect other organs)

male:

  1. Blood urea increased
  2. Glomerular filtration rate decreased
  3. Galactostasis (accumulate too much milk during late pregnancy and lactation)
  4. Lens discolouration
  5. Lymphocyte count decreased
  6. Nipple pain
  7. Nipple swelling
  8. Pyrexia (fever)
  9. Retinal disorder (disease of retina)
  10. Transplant rejection (a transplant material is not worked)

What are the common drug interactions of Cobamamide and Fenofibrate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Blood urea increased
  2. Glomerular filtration rate decreased
  3. Haemoglobin decreased
  4. Urinary tract infection
  5. Protein urine present
  6. Proteinuria (presence of protein in the urine)
  7. Renal failure (kidney dysfunction)
  8. Transplant rejection (a transplant material is not worked)

40-49:

  1. Lymphocyte count decreased

50-59:

  1. Pyrexia (fever)
  2. Tremor (trembling or shaking movements in one or more parts of your body)
  3. Viral infection

60+:

  1. Acute myocardial infarction (acute heart attack)
  2. Mitral valve incompetence (inefficient heart valve)
  3. Cholecystitis infective (infection of gallbladder capable to infect other organs)
  4. Depression
  5. Diarrhoea
  6. Dyspepsia (indigestion)
  7. Dyspnoea (difficult or laboured respiration)
  8. Fibromyalgia (a long-term condition which causes pain all over the body)
  9. Fluid imbalance (imbalance of fluid in body in intake and fluid lost)
  10. Galactostasis (accumulate too much milk during late pregnancy and lactation)

What are the existing conditions these people have? *

  1. High Blood Pressure: 5 people, 35.71%
  2. Lipids Increased (excess lipid in body): 4 people, 28.57%
  3. Urination - Excessive Volume: 4 people, 28.57%
  4. Anaemia (lack of blood): 4 people, 28.57%
  5. Blood Creatinine Increased: 4 people, 28.57%
  6. Heart Disease: 4 people, 28.57%
  7. Red Blood Cell Count Decreased: 4 people, 28.57%
  8. Vasospasm (sudden constriction of a blood vessel, reducing its diameter and flow rate): 4 people, 28.57%
  9. Multiple Myeloma (cancer of the plasma cells): 3 people, 21.43%
  10. Lipids Decreased (less lipid in body): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Cobamamide and Fenofibrate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cobamamide and Fenofibrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cobamamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fenofibrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cobamamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fenofibrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dibencozide and fenofibrate (the active ingredients of Cobamamide and Fenofibrate, respectively), and Cobamamide and Fenofibrate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: